前线
免疫疗法
肺癌
医学
化疗
肿瘤科
重症监护医学
内科学
癌症
历史
考古
作者
Jie Zhao,L.P. Wang,Anda Zhou,Shidi Wen,Wenfeng Fang,Li Zhang,Jianchun Duan,Hua Bai,Jia Zhong,Rui Wan,Boyang Sun,Wei Zhuang,Yi‐Wen Lin,Danming He,Lina Cui,Zhijie Wang,Jie Wang
出处
期刊:Med
[Elsevier]
日期:2024-05-22
卷期号:5 (8): 981-997.e4
标识
DOI:10.1016/j.medj.2024.04.011
摘要
Predictive biomarkers and models of immune checkpoint inhibitors (ICIs) have been extensively studied in non-small cell lung cancer (NSCLC). However, evidence for many biomarkers remains inconclusive, and the opaqueness of machine learning models hinders practicality. We aimed to provide compelling evidence for biomarkers and develop a transparent decision tree model.
科研通智能强力驱动
Strongly Powered by AbleSci AI